boston scientific investor relations

0

Our 2020 Annual Meeting of Stockholders will take place on Thursday, May 7, 2020 . All rights reserved. Investors: Susie Lisa, CFA : 508-683-6585 (office) 508-683-5565 (office) Media Relations : Investor Relations : Boston Scientific Corporation : Boston Scientific Corporation : kate.haranis@bsci.com : BSXInvestorRelations@bsci.com Boston Scientific has been an investor in Preventice since 2015 and currently holds an equity stake of approximately 22 percent, which is expected to result in a net payment of approximately $720 million upon closing and a milestone payment of up to approximately $230 million. Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. Follow on Twitter Follow on Facebook Follow on LinkedIn Follow the rss feed, RM-391807-AA MAY 2016, IC-391808-AA MAY 2016, UroPH-391906-AA MAY 2016, CRM-417209-AA AUG 2016, IC-452206-AA FEB 2017, PI-464317-AA APR 2017. The following information was filed by Boston Scientific Corp (BSX) on Wednesday, February 5, 2020 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. Boston Scientific has been an investor in Preventice since 2015 and currently holds an equity stake of approximately 22 percent, which is expected to result in a net payment of approximately $720 million upon closing and a milestone payment of up to approximately $230 million. Click here for Documents / Information related to Offer to Acquire BTG plc. Investors: Susie Lisa, CFA. 300 Boston Scientific Way Mailstop M405 Marlborough, MA 01752 BSXInvestorRelations@bsci.com . kate.haranis@bsci.com. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. Follow on Twitter Follow on Facebook Follow on LinkedIn Follow the rss feed, RM-391807-AA MAY 2016, IC-391808-AA MAY 2016, UroPH-391906-AA MAY 2016, CRM-417209-AA AUG 2016, IC-452206-AA FEB 2017, PI-464317-AA APR 2017. Investor relations contact. For reconciliations of non-GAAP financial measures to the most directly comparable GAAP figures, please refer to our Financial Disclaimers and Non-GAAP Reconciliations. During the ceremony, Boston Scientific was also recognized as a top five company in the healthcare sector for investor relations. To have a hard copy mailed to you, use the Contact Information , email us at BSXInvestorRelations@bsci.com , call 508-650-8555, or write to Investor Relations, Boston Scientific Corporation, One Boston Scientific Place, MS C-1, Natick, MA 01760-1537. Safe Harbor for forward-looking statements Preventice recorded net sales of $158 million in 2020 – a 30 percent growth rate from the … The company reported GAAP earnings of … Order. 300 Boston Scientific Way Mailstop M405 Marlborough, MA 01752 BSXInvestorRelations@bsci.com. Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming virtual investor conferences. Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. 1 Non-GAAP measure; excludes certain GAAP items. 300 Boston Scientific Way Mailstop M405 Marlborough, MA 01752 BSXInvestorRelations@bsci.com. On this news, Boston Scientific's stock price fell $3.00 per share, or approximately 8%, to close at $35.03 per share on November 17, 2020, thereby injuring investors. Financial Disclaimers and Non-GAAP Reconciliations, ADVANTICS™ Innovative Healthcare Solutions. Boston Scientific Corporation. Boston Scientific Corporation. Investor FAQs; Contact Information; Email Alerts; Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. Connect with Boston Scientific Investor Relations. Investor FAQs; Contact Information; Email Alerts; Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. Quick Links. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could differ materially from the expectations and projections expressed or implied by our forward looking statements. BSXInvestorRelations@bsci.com Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming virtual investor conferences. Boston Scientific has been an investor in Preventice since 2015 and currently holds an equity stake of about 22 percent, which is expected to result in … Apply to Associate, Head of Investor Relations, Customer Relations Representative and more! SUSAN VISSERS LISA is VP of Investor Relations at Boston Scientific Corporation and has served in that role since December 2013. It Takes a Culture of High Performance to Drive Strong Financial Results. Investors: Susie Lisa, CFA : 508-683-6585 (office) 508-683-5565 (office) Media Relations : Investor Relations : Boston Scientific Corporation : Boston Scientific Corporation : kate.haranis@bsci.com : BSXInvestorRelations@bsci.com This website is estimated worth of $ 174,960.00 and have a daily income of around $ 243.00. Quick Links. Forward-looking statements may be identified by words like “anticipate,” “expect,” “project,” “believe,” “plan,” “estimate,” “intend” and similar words. It has a global traffic rank of #82,976 in the world. Additional information about this transaction is available on the events and presentations section of the Boston Scientific investor relations website. Marlborough, Mass. There are currently no events to display. Follow on Twitter Follow on Facebook Follow … Advance your career. Download 2019 Annual Report & 10-K and 2020 Proxy Statement ; JOIN OUR TEAM Rewarding Careers Improving Health. Investor FAQs; Contact Information; Email Alerts; Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients … MARLBOROUGH, Mass., July 29, 2020 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated sales of $2.003 billion during the second quarter of 2020. Through a swift undertaking named Project Shield, Boston Scientific employees assembled and donated 1 million face shields for healthcare providers in just over one month. Privacy Policy Terms of Use Copyright Notice Site Map, Quarterly Results & Non-GAAP Reconciliations, An Open Letter from BSX Leadership on Standing Up to Intolerance & Racism, Q3 2020 Earnings Release and Financial Results, Q3 2020 Financial and Operating Highlights. (February 5, 2020) -- Boston Scientific Corporation (NYSE: BSX) generated sales of $2.905 billion during the fourth quarter of 2019.This represents growth of 13.4 percent on a reported basis, 14.1 percent on an operational 1 basis and 7.3 percent on an organic 2 basis, all compared to the prior year period. This site contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Investor FAQs; Contact Information; Email Alerts; Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. The transaction will consist of an upfront cash payment of … ©2021 Boston Scientific Corporation or its affiliates. Nominees are selected based on the input of hundreds of analysts and investors, who cast their votes and give their opinions on which companies excel in investor relations. And make a meaningful impact on … Connect with Boston Scientific Investor Relations. Connect with Boston Scientific Investor Relations. Privacy Policy Terms of Use Copyright Notice Site Map, Quarterly Results & Non-GAAP Reconciliations, An Open Letter from BSX Leadership on Standing Up to Intolerance & Racism, ADVANTICS™ Innovative Healthcare Solutions. Preventice recorded net sales of $158 million in 2020 – a 30 percent growth rate from … She began her career at JP Morgan Chase & Co and has nearly thirty years of financial and healthcare industry experience. 300 Boston Scientific Way Mailstop M405 Marlborough, MA 01752 BSXInvestorRelations@bsci.com. Follow on Twitter Follow on Facebook Follow … This represents a … LOS ANGELES, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 2, 2021 … Investor FAQs; Contact Information ; Email Alerts; Boston Scientific is dedicated to transforming lives through …

Missouri Form 5633, Lake Wentworth Reservations, The Shootist Streaming, Writers Work Refund, Musical Style Of La Mer, Oberoi Grand Kolkata Buffet Price,

Recent Posts

Leave a Comment